Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FSH Muscular Dystrophy”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Not applicableLooking for participantsNCT06079567
What this trial is testing

An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

Who this might be right for
Facioscapulohumeral Muscular Dystrophy Type 2
Centre Hospitalier Universitaire de Nice 50
Testing effectiveness (Phase 2)Study completedNCT02579239
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Limb-Girdle Muscular DystrophiesFacioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 18
Not applicableStudy completedNCT04999735
What this trial is testing

Digital Biotyping of FSHD Patients and Controls

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Centre for Human Drug Research, Netherlands 58
Testing effectiveness (Phase 2)Study completedNCT02531217
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 9
Testing effectiveness (Phase 2)Ended earlyNCT02927080
What this trial is testing

Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 95
Testing effectiveness (Phase 2)Looking for participantsNCT06907875
What this trial is testing

A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Epicrispr Biotechnologies, Inc. 12
Not applicableEnrolling By InvitationNCT07164937
What this trial is testing

Imaging and Gait Analysis in FSHD Patients

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Large-scale testing (Phase 3)Looking for participantsNCT07038200
What this trial is testing

Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

Who this might be right for
Facioscapulohumeral Muscular DystrophyFSHDFSHD - Facioscapulohumeral Muscular Dystrophy+14 more
Avidity Biosciences, Inc. 200
Not applicableLooking for participantsNCT00082108
What this trial is testing

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

Who this might be right for
Myotonic DystrophyFacioscapulohumeral Muscular DystrophyMuscular Dystrophy+6 more
University of Rochester 3,000
Early research (Phase 1)Looking for participantsNCT07086521
What this trial is testing

Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Restem, LLC. 16
Not applicableLooking for participantsNCT07409142
What this trial is testing

BetterLife FSHD: A Patient-driven Health and Research Platform

Who this might be right for
FSHFSH Muscular DystrophyFSHD - Facioscapulohumeral Muscular Dystrophy+8 more
FSHD Society 5,000
Testing effectiveness (Phase 2)Ended earlyNCT04264442
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 76
Testing effectiveness (Phase 2)Study completedNCT02836418
What this trial is testing

Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular DystrophyLimb Girdle Muscular Dystrophy
aTyr Pharma, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT00104078
What this trial is testing

Study Evaluating MYO-029 in Adult Muscular Dystrophy

Who this might be right for
Becker Muscular DystrophyFacioscapulohumeral Muscular DystrophyLimb-Girdle Muscular Dystrophy
Wyeth is now a wholly owned subsidiary of Pfizer 108
Not applicableStudy completedNCT04267354
What this trial is testing

Arm Cycling in Facioscapulohumeral Dystrophy (FSHD) Patients

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust 15
Not applicableNot Yet RecruitingNCT06086548
What this trial is testing

Unraveling Metabolic Involvement in Facioscapulohumeral Dystrophy Through Metabolomics

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University Hospital, Angers 120
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Not applicableStudy completedNCT00004685
What this trial is testing

Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Ohio State University 90
Not applicableUnknownNCT02541292
What this trial is testing

Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1a
Rigshospitalet, Denmark 10
Testing effectiveness (Phase 2)Ended earlyNCT04004000
What this trial is testing

Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1
Fulcrum Therapeutics 14
Load More Results